Skip to main content

Research Repository

Advanced Search

Circular RNAs in the management of human osteoporosis.

Gargano, Giuseppe; Pagano, Simona M; Maffulli, Nicola

Authors

Giuseppe Gargano

Simona M Pagano

Nicola Maffulli



Abstract

Osteoporosis (OP) is a metabolic bone disease producing reduction in bone mass with consequent bone fragility. Circular ribonucleic acid (CircRNA) is a form of RNA that forms a loop structure rather than a linear one. CircRNA can be used for therapeutic purposes, including molecular targets or to test new therapies. A systematic search of different databases to July 2024 was performed to define the role of circRNA in OP therapy. Seventeen suitable studies were identified. CircRNAs may be useful in studying metabolic processes in OP and identify possible therapeutic targets and new drug therapies. The metabolic processes involved in OP are regulated by many genes and cytokines that can be targeted by CircRNAs. However, it is not easy to predict whether the in vitro responses of the studied CircRNAs and their interaction with drugs are also applicable in vivo. Metabolic processes can be affected by gene dysregulation of CircRNAs on various growth factors. Areas timely for developing research: Despite the predictability of CircRNA pharmacological response in vitro, such pharmacological response cannot be expected to be replicated in vivo. The data that support the findings of this study are available from the corresponding author. [Abstract copyright: © The Author(s) 2025. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.]

Citation

Gargano, G., Pagano, S. M., & Maffulli, N. (2025). Circular RNAs in the management of human osteoporosis. British Medical Bulletin, 153(1), https://doi.org/10.1093/bmb/ldae024

Journal Article Type Article
Acceptance Date Dec 15, 2024
Online Publication Date Jan 16, 2025
Publication Date Jan 16, 2025
Deposit Date Mar 19, 2025
Journal British medical bulletin
Print ISSN 0007-1420
Publisher Oxford University Press
Peer Reviewed Peer Reviewed
Volume 153
Issue 1
DOI https://doi.org/10.1093/bmb/ldae024
Keywords ribonucleic acid silencing, osteoporosis therapy, RNA, Circular - genetics, Osteoporosis - genetics - therapy - metabolism, Humans, osteoporosis, circular ribonucleic acid, ribonucleic acid interference
Public URL https://keele-repository.worktribe.com/output/1053595
Publisher URL https://academic.oup.com/bmb/article/153/1/ldae024/7958569